Roche/Syntex
Executive Summary
Final consent agreement with FTC on merger calls for divestiture of Syva medical diagnostics business in the U.S. within 12 months. Syva, with worldwide sales of $212 mil. in fiscal 1993, is engaged primarily in testing for drugs of abuse, therapeutic drug monitoring and disease diagnosis...